DEA’s Diversion Control Division strives to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources. When the safety and health of the American people is in jeopardy, DEA takes action against those who violate the law.
Read the latest enforcement cases and civil actions:
|
May 31, 2023
The United States and Montgomery County Based Pharmacy and Pharmacist Reach a Consent Decree Over Allegations of Illegally Dispensed Controlled Substances
June 13, 2023
Gloucester County Man Admits Healthcare Fraud
June 14, 2023
Pocatello Nurse Practitioner is Fined and Surrenders License for Unlawful Prescriptions and Fraud
June 16, 2023
Former Alaska Advanced Nurse Practitioner Sentenced to 30 Years for Illegally Prescribing Millions of Opioids Causing Five Deaths
June 22, 2023
Cheshire Medical Center to Pay $2 Million to Settle Allegations of Controlled Substances Act Violations
June 22, 2023
San Jose Doctor Convicted of Twelve Counts of Illegally Prescribing Opioids
June 22, 2023
Catskill Pharmacy Pays $65,000 to Resolve Controlled Substances Act Allegations
June 23, 2023
Doctor Convicted of Illegally Distributing Opioids and Other Drugs
June 23, 2023
Three Chinese Chemical Manufacturing Companies and Five Employees Charged with Conspiring to Manufacture Fentanyl
June 23, 2023
Jury Convicts Pain Clinic Doctor of Unlawful Drug Distribution, Money Laundering, and Filing a False Tax Return
June 23, 2023
Dentist Convicted of Unlawfully Distributing Opioids That Caused Patient’s Death
June 23, 2023
Wilmington Doctor to Pay $170,000 to Resolve Allegations of Unlawful Prescribing of Opioids
June 26, 2023
CVS To Pay $70,000 To Resolve Allegations That It Filled Fake Prescriptions
June 26, 2023
Fourth Circuit Upholds Former Tabor City Doctor’s Conviction for Operating a Pill Mill
|
